Sign in Subscribe
Cancer research

High HMGB1 Levels Contribute to Colon Cancer Development and Metastasis

Strategic Insights

— 1 min read

A recent study published in Nucleosides, Nucleotides & Nucleic Acids has shed light on the role of HMGB1 in colon cancer. Researchers from Yancheng First People's Hospital in Jiangsu, China, investigated the association between a functional InDel polymorphism (rs34000982) on the HMGB1 gene and colon cancer susceptibility, tumor stage, and the clinical relevance of gene expression. The study involved a cohort of 600 colon cancer patients and 600 healthy control individuals, who were genotyped using a polymerase chain reaction-polyacrylamide gel electrophoresis assay.

The findings demonstrated that the rs34000982 Ins allele or Ins/Ins genotype was associated with reduced susceptibility to colon cancer, particularly stage III-IV colon cancer. The research concluded that the rs34000982 polymorphism may serve as a marker of colon cancer susceptibility and progression in the Chinese population, and HMGB1 levels may serve as an anti-colon cancer drug sensitivity marker.

Key Takeaways:

  • High HMGB1 levels contribute to the development and metastasis of tumors, including colorectal cancer (CRC).
  • The rs34000982 functional InDel polymorphism on the HMGB1 gene is associated with reduced susceptibility to CRC, especially stage III-IV CRC.
  • The rs34000982 polymorphism may serve as a marker of CRC susceptibility and progression in the Chinese population.
  • HMGB1 levels may serve as an anti-CRC drug sensitivity marker.
  • The study involved a cohort of 600 CRC patients and 600 healthy control individuals.
  • The research was conducted by a team of researchers from Yancheng First People's Hospital in Jiangsu, China.
  • The study concluded that the HMGB1 gene polymorphism has clinical relevance and function in CRC.
  • The findings have implications for the diagnosis and treatment of colon cancer.

Statistics:

  • OR = 0.65 for the association between the rs34000982 Ins allele and reduced susceptibility to CRC.
  • 95%CI = 0.51-0.82 for the association between the rs34000982 Ins allele and reduced susceptibility to CRC.
  • 600 CRC patients and 600 healthy control individuals were involved in the study.
  • The study demonstrated a significant association between the rs34000982 polymorphism and CRC susceptibility in the Chinese population.

Sources:

  • Clinical relevance and function of HMGB1 gene polymorphism and expression in colorectal cancer. Nucleosides, Nucleotides & Nucleic Acids, 2024;44(10):836-846.
  • Nucleosides, Nucleotides & Nucleic Acids can be contacted at: Taylor & Francis Inc, 530 Walnut Street, Ste 850, Philadelphia, PA 19106, USA.

Read more